Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for bone metabolism in diabetic nephropathy
ChiCTR-OCH-11001837Phase 4Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alendronate in diabetic glomerulosclerosis, osteoporosis and low bone mineral density (3 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Bone mineral density. Started Dec 2011; status: completed.
02
Drugs
alendronate
03
Conditions
diabetic glomerulosclerosisosteoporosislow bone mineral density
Beyond the preview
Go deeper on ChiCTR-OCH-11001837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-11001837.